Literature DB >> 422241

Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.

K McIntosh, J McQuillin, P S Gardner.   

Abstract

Twenty-two infants under 9 months of age hospitalized with bronchiolitis or pneumonia due to respiratory syncytial virus (RSV) were serially sampled to determine the pattern of secretory antibody response. Using double labeling techniques, we found several types of immunoglobulin in secretions: cell-free antibody to RSV of the immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM) classes; and immunoglobulins of all three classes bound to RSV-infected cells shed from the nasal epithelium (presumably cell-bound antibody to RSV). IgA attached to RSV-infected epithelial cells was almost always detected in the first available nasal sample (day 1 or 2 of hospitalization). In contrast, cell-free anti-RSV IgA first appeared an average of 3.5 days later at a time when virus antigen was disappearing from the secretion. IgG and IgM attached to RSV-infected cells appeared more irregularly. The titer of cell-free anti-RSV IgM was often higher than that of IgA early in the illness and declined as the infection resolved. Cell-free anti-RSV IgG was usually present earlier than IgA and rose during convalescence.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422241      PMCID: PMC414160          DOI: 10.1128/iai.23.2.276-281.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  The coating of respiratory syncytial (RS) virus-infected cells in the respiratory tract by immunoglobulins.

Authors:  P S Gardner; J McQuillin
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

2.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

3.  Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection.

Authors:  H W Kim; J A Bellanti; J O Arrobio; J Mills; C D Brandt; R M Chanock; R H Parrott
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

4.  The immunologic response to infection with respiratory syncytial virus in infants.

Authors:  K McIntosh; H B Masters; I Orr; R K Chao; R M Barkin
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

5.  Detection of antibody to respiratory syncytial virus by membrane fluorescence.

Authors:  R Scott; M O De Landazuri; P S Gardner; J J Owen
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

6.  The local antibody response to R.S. virus infection in the respiratory tract.

Authors:  R Scott; P S Gardner
Journal:  J Hyg (Lond)       Date:  1974-02

7.  Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions.

Authors:  R Scott; P S Gardner
Journal:  J Hyg (Lond)       Date:  1970-12

8.  Inhibition of virus release by antibodies to surface antigens of influenza viruses.

Authors:  W R Dowdle; J C Downie; W G Laver
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

9.  Speculation on pathogenesis in death from respiratory syncytial virus infection.

Authors:  P S Gardner; J McQuillin; S D Court
Journal:  Br Med J       Date:  1970-02-07
  9 in total
  31 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Protective effect of serum antibody on respiratory infection of influenza C virus in rats.

Authors:  K Takiguchi; K Sugawara; S Hongo; H Nishimura; F Kitame; K Nakamura
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 3.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus.

Authors:  John P DeVincenzo; Tom Wilkinson; Akshay Vaishnaw; Jeff Cehelsky; Rachel Meyers; Saraswathy Nochur; Lisa Harrison; Patricia Meeking; Alex Mann; Elizabeth Moane; John Oxford; Rajat Pareek; Ryves Moore; Ed Walsh; Robert Studholme; Preston Dorsett; Rene Alvarez; Robert Lambkin-Williams
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

5.  Production of interferon in respiratory syncytial virus bronchiolitis.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

6.  Respiratory syncytial virus and the infant immune response.

Authors:  G L Toms; R Scott
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

7.  Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.

Authors:  R Sharma; Z Woldehiwet
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

8.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.

Authors:  T N Kaul; R C Welliver; P L Ogra
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.